Format

Send to

Choose Destination
Chem Commun (Camb). 2012 Dec 7;48(94):11567-9. doi: 10.1039/c2cc36456e.

Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy.

Author information

1
State Key Laboratory of Urban Water Resources and Environment, School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150001, China.

Abstract

Herein, prussian blue nanoparticles, an ancient dye, were explored as a new generation of near-infrared laser-driven photothermal ablation agents for cancer therapy alternative to traditional agents due to their good photothermal efficiency and high photothermal stability but low cost and particularly clinically approved biosafety.

PMID:
23090583
DOI:
10.1039/c2cc36456e
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Royal Society of Chemistry
Loading ...
Support Center